Das HER2-positive metastasierte Mammakarzinom – Aktuelle Behandlungskonzepte (UNI-MED Science) (German Edition)

By Manfred Welslau
Das vorliegende Buch soll den Bogen über mehr als 30 Jahre präklinische und klinische Erkenntnisse der Behandlung des HER2-positiven metastasierten Mammakarzinoms schlagen. Die Prognose und die Überlebenszeiten haben sich durch die Entwicklung der Medikamente gegen den HER2/neu-Rezeptor bei dieser Erkrankung erheblich verbessert. Die wichtigsten wissenschaftlichen Daten, die bisher erarbeitet wurden, sind hier kompakt dargestellt. Daneben soll dieses Buch die Wichtigkeit einer patientenzentrierten Versorgung in dieser Krankheitssituation darstellen und auch hier neue Perspektiven aufzeigen.

The book ‘Behandlung des HER2-positiven metastasierten Mammakarzinoms’ by Manfred Welslau, delves into over 30 years of preclinical and clinical research on the treatment of HER2-positive metastatic breast cancer. This comprehensive guide discusses the significant improvements in prognosis and survival rates that have been achieved through the development of medications targeting the HER2/neu receptor.

With a compact presentation of the most important scientific data accumulated thus far, the book offers a wealth of knowledge in a concise format. In addition to providing a comprehensive overview of the research, ‘Behandlung des HER2-positiven metastasierten Mammakarzinoms’ emphasizes the importance of patient-centered care in this disease context, shedding light on new perspectives for treatment and care.

The wealth of information contained within the pages of this book makes it a valuable resource for medical professionals, researchers, and anyone interested in understanding and treating HER2-positive metastatic breast cancer. Manfred Welslau, a respected expert in the field, brings his extensive knowledge and expertise to bear, providing readers with insights and analysis that can inform and guide their approach to patient care.

One of the key strengths of ‘Behandlung des HER2-positiven metastasierten Mammakarzinoms’ is its ability to condense a large body of scientific research into a format that is accessible and understandable for a wide range of readers. The book presents complex medical information in a clear and concise manner, ensuring that even individuals without a medical background can grasp the key concepts.

Moreover, this book not only serves as a compendium of research findings but also highlights the importance of patient-centered care. It underscores the need to consider the individual needs and preferences of patients in the treatment of HER2-positive metastatic breast cancer. By emphasizing this patient-centric approach, the author encourages healthcare providers to tailor their care to the specific circumstances of each patient, fostering a more holistic and effective treatment experience.

The book also offers new perspectives on the treatment of HER2-positive metastatic breast cancer. By exploring the latest research and developments, Manfred Welslau opens up possibilities for innovative approaches to patient care and treatment. These new perspectives can challenge existing paradigms and inspire healthcare professionals to think outside the box, potentially leading to improved outcomes for patients.

Overall, ‘Behandlung des HER2-positiven metastasierten Mammakarzinoms’ is a must-read for healthcare professionals, researchers, and anyone interested in advancing their understanding and treatment of HER2-positive metastatic breast cancer. With its comprehensive coverage of over 30 years of research, emphasis on patient-centered care, and exploration of new perspectives, this book offers a valuable resource that can inform and inspire those involved in the field.

Order your copy of ‘Behandlung des HER2-positiven metastasierten Mammakarzinoms’ today and join the growing community of professionals dedicated to improving the lives of those affected by HER2-positive metastatic breast cancer. Expand your knowledge, gain insights from the latest research, and discover new perspectives that can make a difference in patient care and treatment strategies.

Product Details

• ASIN ‏ : ‎ B0C33XVKPM
• Publisher ‏ : ‎ UNI-MED Verlag AG; 1st edition (April 3, 2023)
• Publication date ‏ : ‎ April 3, 2023
• Language ‏ : ‎ German